[1] STANISLAV S. RUBAKHIN. Profiling Signaling Peptides in Single Mammalian Cells Using Mass Spectrometry[J]. Analytical Chemistry, 2006, 78 20: 7267-7272. DOI:
10.1021/ac0607010[2] RUTA MUCENIECE . The MC3 receptor binding affinity of melanocortins correlates with the nitric oxide production inhibition in mice brain inflammation model[J]. Peptides, 2006, 27 6: Pages 1443-1450. DOI:
10.1016/j.peptides.2005.12.002[3] SHOGO OKI . ‘γ-MSH’ fragments from ACTH-β-LPH precursor have an affinity for opiate receptors[J]. European journal of pharmacology, 1980, 64 2: Pages 161-164. DOI:
10.1016/0014-2999(80)90039-4[4] YOJIRO MUNEOKA Hitoshi S. Pharmacology of fmrfamide in Mytilus catch muscle[J]. Comparative biochemistry and physiology. C: Comparative pharmacology, 1986, 85 1: Pages 207-214. DOI:
10.1016/0742-8413(86)90075-7[5] V. KLUSA . The g2-MSH peptide mediates a central analgesic effect via a GABA-ergic mechanism that is independent from activation of melanocortin receptors[J]. Neuropeptides, 2001, 35 1: Pages 50-57. DOI:
10.1054/npep.2000.0843